124 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
to stabilize, turnaround and transform 5 Our mission is unchanged Q1 2024 stabilization efforts and priorities: Continued focus on MCM and NARCAN® Nasal
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
.
At Emergent, our mission is to protect and enhance life. We develop, manufacture, and deliver protections against public health threats through
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
Executive Officer 55
Transformation Plan Update 6 Transformation Plan Update Multi-year plan to stabilize, turnaround and transform. Our mission
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
4:05pm
commitment to Emergent’s mission and ongoing resilience to change,” stated Michelle Pepin, SVP and chief human resources officer. “We will work … , a press release announcing an amendment to Emergent’s credit facility was also recently filed.
About Emergent BioSolutions
At Emergent, our mission
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
30 Apr 24
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
5:22pm
2024 financial review, and FY 2024 and Q2 2024 guidance.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For 25
8-K
EX-99.2
2e6qtr8 kpsslyw99wu
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
9an0nbu0w6mtb4m6hv4
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
gifsdnga6z58tg
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-99.1
nycwyr
11 Jan 24
Other Events
7:41am
8-K
EX-99.2
2pqz091wd7kwlrtfoj
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
7wv6e8z8awnpgh7ub ma
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
it87 3g4eu
28 Nov 23
Other Events
7:15am
8-K
EX-99.1
u7n155b23tjjf ref
24 Nov 23
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
7:17am
8-K
EX-99.1
6dq7 0xe4
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
o5rhxbuty8dzv8ux 1w
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am
8-K
EX-99.1
zs8riaev3
30 Aug 23
Other Events
6:30am
8-K
EX-99.1
fw3 kie4kng1r
16 Aug 23
Emergent’s Statement Regarding the Passing of a Director of the Board
4:47pm
8-K
EX-99.1
hprexf6utkrei np
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm